Delivery Order SPE2DB20D3104-SPE2DB22FV9N7

Award Date 9/15/22
Potential Completion Date 9/16/22
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 syringes. The $4,767.17 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Cosentyx 300 mg dose - 2 syringes. The $2,297.14 firm fixed-price delivery order has a completion date of February 5, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.95 firm fixed-price delivery order is for the supply of Cosentyx 300mg dose medical products. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,943.53 firm fixed-price delivery order is for the supply of Cosentyx (300mg dose) medication. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,649.75 for the supply of Cosentyx 300 mg dose syringes. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense that provides logistics, acquisition, and technical services to the U.S. military. The contract is a firm fixed-price delivery order with a completion date of March 30, 2023. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,565.85 firm-fixed-price delivery order is for the supply of Cosentyx 150 mg/ml pen injectable medication. The contract has a completion date of May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,548.93 fixed-price delivery order is for the supply of Cosentyx 300 mg dose-2 prefilled syringes. The contract has a completion date of June 30, 2022 and was awarded on June 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,087.84, is for the delivery of Cosentyx 300mg injections. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 14, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Cosentyx 300 mg dose pre-filled syringes. The $1,493.13 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 4, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Cosentyx (secukinumab) 300mg injector pens to the U.S. government. The firm-fixed-price Delivery Order, valued at $6,329.60, has a completion date of May 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV9N7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cosentyx 300 mg dose syringes. The $3,278.30 firm fixed-price delivery order has a completion date of September 16, 2022.

AmerisourceBergen holds two larger Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively. These IDCs enable the company to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, syringes, and other critical medical commodities, to support military, veterans', and other federal healthcare programs. The contract award did not include any set-aside designations.

Generated 2/27/25, 10:16 AM